Pharma & Patient USA 2022

The only destination for North American patient centricity leaders

Patient experiences are too often long, lonely, confusing, and financially troubling. It is easy for mistrust to build between pharma and patients, causing a decline in adherence, trial participation and health outcomes across all patient groups, especially underserved communities.

It is time for pharma to revolutionize the patient experience.

So where do we begin? Step one, map the patient experience and identify new partners that will help you uncover engagement gaps. Step two, deep-dive personalized insights direct from patients that align workstreams across the value chain. Step three, listen, integrate, and action feedback to ensure effective delivery on community commitments

Connect the dots across the patient ecosystem at Reuters Events: Pharma & Patient USA 2022, where industry leaders and patient advocates will gather to bridge new partnerships, advance health outcomes for patients in underserved communities and rebuild trust within the expanding patient community.


2022’s industry defining themes:
- Discover new partnerships across the patient ecosystem: Identify and connect with untapped stakeholders to co-create seamless patient and HCP journeys
- Tackle health inequities throughout the value chain: Diversity, Equity, and Inclusion (DEI) workstreams can go so much further. Outline a roadmap for significant improvement in minority health outcomes across trial diversity, community trust-building, and increased access to patient support
- Synchronize organizational workflows to enhance patient journeys: Collaborate across functions to uncover and address gaps in the patient journey, and improve the end-to-end patient experience
- Champion patient feedback across all patient experiences: Ensure patient co-creation, shared decision making with HCPs and feedback opportunities exist throughout the patient journey to empower patients, improve adherence, and increase quality of life